Antimicrobial Hospital Textile Market Size, Share, Growth Report 2030

Antimicrobial Hospital Textile Market

Global Antimicrobial Hospital Textile Market By Application (Medical Uniform & Apparels, Upholstery, Surgical Textiles, Incontinence Care Garments, Wound Treatment, and Others), By FDA Class (Class I, Class II and Class III), By Finishing Agent (Quaternary Ammonium, Metallic Salts and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2028

Category: Chemical & Materials Report Format : PDF Pages: 120 Report Code: ZMR-4638 Published Date: Jun-2021 Status : Published

The Global Antimicrobial Hospital Textile Market accounted for USD 9.45 Billion in 2020 and is expected to reach USD 14.79 Billion by 2028, growing at a CAGR of 6.6% from 2020 to 2028.

Antimicrobial Hospital Textile Market

Table Of Content

  • Chapter No. 1: Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2: Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Application
        • 2.1.1.2. Market Attractiveness Analysis, By FDA Class
        • 2.1.1.3. Market Attractiveness Analysis, By Finishing Agent
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Antimicrobial Hospital Textile Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3: COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4: Antimicrobial Hospital Textile Market – Application Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 4.2. Medical Uniform & Apparels
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Uphulstery
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Surgical Textiles
      • 4.4.1. Market Size and Forecast, By Region (USD Million)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Incontinence Care Garments
      • 4.5.1. Market Size and Forecast, By Region (USD Million)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.6. Wound Treatment
      • 4.6.1. Market Size and Forecast, By Region (USD Million)
      • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.7. Others
      • 4.7.1. Market Size and Forecast, By Region (USD Million)
      • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5: Antimicrobial Hospital Textile Market – FDA Class Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By FDA Class, 2020 & 2028
    • 5.2. Class I
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Class II
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Class III
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6: Antimicrobial Hospital Textile Market – Finishing Agent Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Finishing Agent, 2020 & 2028
    • 6.2. Quaternary Ammonium
      • 6.2.1. Market Size and Forecast, By Region (USD Million)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Metallic Salts
      • 6.3.1. Market Size and Forecast, By Region (USD Million)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Others
      • 6.4.1. Market Size and Forecast, By Region (USD Million)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7: Antimicrobial Hospital Textile Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.2.2. North America Market Revenue, By Application, 2016 – 2028
      • 7.2.3. North America Market Revenue, By FDA Class, 2016 – 2028
      • 7.2.4. North America Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Application, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By FDA Class, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Application, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By FDA Class, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Application, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By FDA Class, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.3.2. Europe Market Revenue, By Application, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By FDA Class, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Application, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By FDA Class, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Application, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By FDA Class, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Application, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By FDA Class, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Application, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By FDA Class, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Application, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By FDA Class, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Application, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By FDA Class, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.4.2. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By FDA Class, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Application, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By FDA Class, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Application, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By FDA Class, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Application, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By FDA Class, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Application, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By FDA Class, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Application, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By FDA Class, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By FDA Class, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.5.2. Latin America Market Revenue, By Application, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By FDA Class, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Application, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By FDA Class, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Application, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By FDA Class, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Application, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By FDA Class, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By Finishing Agent, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By FDA Class, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Application, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By FDA Class, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Application, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By FDA Class, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By Finishing Agent, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By FDA Class, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Finishing Agent, 2016 – 2028
  • Chapter No. 8: Antimicrobial Hospital Textile Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Technology Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9: Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Antimicrobial Hospital Textile Market: Company Market Share, 2019
      • 9.1.2. Global Antimicrobial Hospital Textile Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 9.1.3. Global Antimicrobial Hospital Textile Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Antimicrobial Hospital Textile Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10: Company Profiles
    • 10.1. Baltex
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfolio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. Meditex Technology
    • 10.3. Surgicotfab Textiles Private Limited
    • 10.4. Medtronic
    • 10.5. Toyobo Co. Ltd.
    • 10.6. Smartfiber AG
    • 10.7. Swicofil AG
    • 10.8. Herculite Inc.
    • 10.9. Smith & Nephew Plc.
    • 10.10. Sinterama
  • Chapter No. 11: Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Environmental Change
  • Chapter No. 12: Research Methodology
    • 12.1. Research Methodology
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

Table Of Figures

List of Figures  

FIG NO. 1. Market Attractiveness Analysis, By Application 
FIG NO. 2. Market Attractiveness Analysis, By FDA Class 
FIG NO. 3. Market Attractiveness Analysis, By Finishing Agent 
FIG NO. 4. Market Attractiveness Analysis, By Region 
FIG NO. 5. Global Antimicrobial Hospital Textile Market Revenue, 2016 – 2028 (USD Million 
FIG NO. 6. Impact of COVID-19 Pandemic in North America Countries 
FIG NO. 7. Market Revenue Share, By Application, 2020 & 2028 
FIG NO. 8. Global Antimicrobial Hospital Textile Market for Medical Uniform & Apparels, Revenue (USD Million) 2016 – 2028 
FIG NO. 9. Comparative Revenue Analysis of Antimicrobial Hospital Textile Market for Medical Uniform & Apparels, By Country, 2020 & 2028 
FIG NO. 10. Global Antimicrobial Hospital Textile Market for Upholstery, Revenue (USD Million) 2016 – 2028 
FIG NO. 11. Comparative Revenue Analysis of Antimicrobial Hospital Textile Market for Upholstery, By Country, 2020 & 2028 
FIG NO. 12. Global Antimicrobial Hospital Textile Market for Surgical Textiles, Revenue (USD Million) 2016 – 2028 
FIG NO. 13. Comparative Revenue Analysis of Antimicrobial Hospital Textile Market for Surgical Textiles, By Country, 2020 & 2028 
FIG NO. 14. Global Antimicrobial Hospital Textile Market for Incontinence Care Garments, Revenue (USD Million) 2016 – 2028 
FIG NO. 15. Comparative Revenue Analysis of Antimicrobial Hospital Textile Market for Incontinence Care Garments, By Country, 2020 & 2028 
FIG NO. 16. Global Antimicrobial Hospital Textile Market for Wound Treatment, Revenue (USD Million) 2016 – 2028 
FIG NO. 17. Comparative Revenue Analysis of Antimicrobial Hospital Textile Market for Wound Treatment, By Country, 2020 & 2028 
FIG NO. 18. Global Antimicrobial Hospital Textile Market for Others, Revenue (USD Million) 2016 – 2028 
FIG NO. 19. Comparative Revenue Analysis of Antimicrobial Hospital Textile Market for Others, By Country, 2020 & 2028 
FIG NO. 20. Market Revenue Share, By FDA Class, 2020 & 2028 
FIG NO. 21. Global Antimicrobial Hospital Textile Market for Class I, Revenue (USD Million) 2016 – 2028 
FIG NO. 22. Comparative Revenue Analysis of Antimicrobial Hospital Textile Market for Class I, By Country, 2020 & 2028 
FIG NO. 23. Global Antimicrobial Hospital Textile Market for Class II, Revenue (USD Million) 2016 – 2028 
FIG NO. 24. Comparative Revenue Analysis of Antimicrobial Hospital Textile Market for Class II, By Country, 2020 & 2028 
FIG NO. 25. Global Antimicrobial Hospital Textile Market for Class III, Revenue (USD Million) 2016 – 2028 
FIG NO. 26. Comparative Revenue Analysis of Antimicrobial Hospital Textile Market for Class III, By Country, 2020 & 2028 
FIG NO. 27. Market Revenue Share, By Finishing Agent, 2020 & 2028 
FIG NO. 28. Global Antimicrobial Hospital Textile Market for Quaternary Ammonium, Revenue (USD Million) 2016 – 2028 
FIG NO. 29. Comparative Revenue Analysis of Antimicrobial Hospital Textile Market for Quaternary Ammonium, By Country, 2020 & 2028 
FIG NO. 30. Global Antimicrobial Hospital Textile Market for Metallic Salts, Revenue (USD Million) 2016 – 2028 
FIG NO. 31. Comparative Revenue Analysis of Antimicrobial Hospital Textile Market for Metallic Salts, By Country, 2020 & 2028 
FIG NO. 32. Global Antimicrobial Hospital Textile Market for Others, Revenue (USD Million) 2016 – 2028 
FIG NO. 33. Comparative Revenue Analysis of Antimicrobial Hospital Textile Market for Others, By Country, 2020 & 2028 
FIG NO. 34. Global Antimicrobial Hospital Textile Market Revenue Share, By Region, 2020 & 2028 
FIG NO. 35. North America Antimicrobial Hospital Textile Market Revenue, 2016 - 2028 (USD Million) 
FIG NO. 36. Porter’s Five Forces Analysis for Global Antimicrobial Hospital Textile Market 
FIG NO. 37. PEST Analysis for Global Antimicrobial Hospital Textile Market 
FIG NO. 38. Pricing Analysis for Global Antimicrobial Hospital Textile Market 
FIG NO. 39. Value Chain Analysis for Global Antimicrobial Hospital Textile Market 
FIG NO. 40. Company Share Analysis, 2019 
FIG NO. 41. Radar Determinant Chart, 2019 
FIG NO. 42. Company Strategic Developments – Heat Map Analysis 
FIG NO. 43. Baltex Business Segment Revenue Share, 2020 (%) 
FIG NO. 44. Baltex Geographical Segment Revenue Share, 2020 (%) 
FIG NO. 45. Market Channels 
FIG NO. 46. Marketing Channel Development Trend 
FIG NO. 47. Growth in World Gross Product, 2008-2018 
FIG NO. 48. Research Methodology – Detailed View 
FIG NO. 49. Research Methodology 


Table Of Tables

List of Tables  

TABLE NO. 1: Global Antimicrobial Hospital Textile Market: Snapshot 
TABLE NO. 2: Quarterly Antimicrobial Hospital Textile Market Revenue by Region, 2020 
TABLE NO. 3: Quarterly Antimicrobial Hospital Textile Market Revenue Forecast by Region, 2021 
TABLE NO. 4: Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million) 
TABLE NO. 5: Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million) 
TABLE NO. 6: Global Antimicrobial Hospital Textile Market for Medical Uniform & Apparels, by Region, 2016 – 2028 (USD Million) 
TABLE NO. 7: Global Antimicrobial Hospital Textile Market for Upholstery, by Region, 2016 – 2028 (USD Million) 
TABLE NO. 8: Global Antimicrobial Hospital Textile Market for Surgical Textiles, by Region, 2016 – 2028 (USD Million) 
TABLE NO. 9: Global Antimicrobial Hospital Textile Market for Incontinence Care Garments, by Region, 2016 – 2028 (USD Million) 
TABLE NO. 10: Global Antimicrobial Hospital Textile Market for Wound Treatment, by Region, 2016 – 2028 (USD Million) 
TABLE NO. 11: Global Antimicrobial Hospital Textile Market for Others, by Region, 2016 – 2028 (USD Million) 
TABLE NO. 12: Global Antimicrobial Hospital Textile Market for Class I, by Region, 2016 – 2028 (USD Million) 
TABLE NO. 13: Global Antimicrobial Hospital Textile Market for Class II, by Region, 2016 – 2028 (USD Million) 
TABLE NO. 14: Global Antimicrobial Hospital Textile Market for Class III, by Region, 2016 – 2028 (USD Million) 
TABLE NO. 15: Global Antimicrobial Hospital Textile Market for Quaternary Ammonium, by Region, 2016 – 2028 (USD Million) 
TABLE NO. 16: Global Antimicrobial Hospital Textile Market for Metallic Salts, by Region, 2016 – 2028 (USD Million) 
TABLE NO. 17: Global Antimicrobial Hospital Textile Market for Others, by Region, 2016 – 2028 (USD Million) 
TABLE NO. 18: Global Antimicrobial Hospital Textile Market Revenue, By Region, 2016 – 2028 (USD Million) 
TABLE NO. 19: North America Antimicrobial Hospital Textile Market Revenue, By Country, 2016 – 2028 (USD Million) 
TABLE NO. 20: North America Antimicrobial Hospital Textile Market Revenue, By Application, 2016 – 2028 (USD Million) 
TABLE NO. 21: North America Antimicrobial Hospital Textile Market Revenue, By FDA Class, 2016 – 2028 (USD Million) 
TABLE NO. 22: North America Antimicrobial Hospital Textile Market Revenue, By Finishing Agent, 2016 – 2028 (USD Million) 
TABLE NO. 23: U.S. Antimicrobial Hospital Textile Market Revenue, By Application, 2016 – 2028 (USD Million) 
TABLE NO. 24: U.S. Antimicrobial Hospital Textile Market Revenue, By FDA Class, 2016 – 2028 (USD Million) 
TABLE NO. 25: U.S. Antimicrobial Hospital Textile Market Revenue, By Finishing Agent, 2016 – 2028 (USD Million) 
TABLE NO. 26: Canada Antimicrobial Hospital Textile Market Revenue, By Application, 2016 – 2028 (USD Million) 
TABLE NO. 27: Canada Antimicrobial Hospital Textile Market Revenue, By FDA Class, 2016 – 2028 (USD Million) 
TABLE NO. 28: Canada Antimicrobial Hospital Textile Market Revenue, By Finishing Agent, 2016 – 2028 (USD Million) 
TABLE NO. 29: Mexico Antimicrobial Hospital Textile Market Revenue, By Application, 2016 – 2028 (USD Million) 
TABLE NO. 30: Mexico Antimicrobial Hospital Textile Market Revenue, By FDA Class, 2016 – 2028 (USD Million) 
TABLE NO. 31: Mexico Antimicrobial Hospital Textile Market Revenue, By Finishing Agent, 2016 – 2028 (USD Million) 
TABLE NO. 32: Drivers for the Antimicrobial Hospital Textile Market: Impact Analysis 
TABLE NO. 33: Restraints for the Antimicrobial Hospital Textile Market: Impact Analysis 
TABLE NO. 34: Major Buyers of Antimicrobial Hospital Textile 
TABLE NO. 35: Distributors/Traders List of Antimicrobial Hospital Textile 
TABLE NO. 36: Global Antimicrobial Hospital Textile Market, Company Market Revenue, 2016 – 2019 (USD Million) 
TABLE NO. 37: Global Antimicrobial Hospital Textile Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million) 
 

Methodology

FrequentlyAsked Questions

The Global Antimicrobial Hospital Textile Market was valued at USD 9.45 Billion in 2020.

The Global Antimicrobial Hospital Textile Market is expected to reach USD 14.79 Billion by 2028, growing at a CAGR of 6.6 % between 2021 to 2028.

Growing consumer awareness about hygiene in emerging market and Rising demand for antimicrobial sportswear and apparel are the major key factors driving the Global Antimicrobial Hospital Textile Market growth.

Asia-Pacific is projected to be the fastest growing country in Global Antimicrobial Hospital Textile Market. During the forecast period, it is projected to rise at a CAGR of 9.20%

Some of the prominent players operating in the Global Antimicrobial Hospital Textile Market are Baltex, Meditex Technology, Surgicotfab Textiles Private Limited, Medtronic, Toyobo Co. Ltd., Smartfiber AG, Swicofil AG, Herculite Inc., Smith & Nephew Plc., Sinterama and Others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed